$13.1MSeries C, 31 March 2026
Series C to expand Dr. Noon CVD, pursue US FDA approval and prepare a KOSDAQ listing
- Amount
- $13.1M
- Stage
- Series C
- Announced
- 31 March 2026
- Lead
- Premier Partners
- Other investors
- KB Investment, Quad Investment Management, IMM Investment, Hana Ventures, AON Investment, Startup Partners
- Use of funds
- Series C to expand Dr. Noon CVD, pursue US FDA approval and prepare a KOSDAQ listing
- Checked
- Amount and date checked against the press source
- Source
- Mediwhale completes ₩20B investment venturesquare.net